Robatumumab
Robatumumab (Sch 717454) is an anti-human IGF-1R (insulin-like growth factor receptor-1) antibody. Robatumumab shows anti-tumor activity and anti-proliferative activity to cancer cells. Robatumumab can be used in osteosarcoma and Ewing sarcoma research[1][2].
Product Specifications
CAS Number
934235-44-6
Product Name Alternative
Sch 717454; 19D12
UNSPSC
12352203
Target
IGF-1R
Type
Inhibitory Antibodies
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/robatumumab.html
Purity
99.90
Solubility
10 mM in DMSO
Smiles
[Robatumumab]
Molecular Weight
(146.36 kDa)
References & Citations
[1]Anderson PM, et al. A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma. Pediatr Blood Cancer. 2016 Oct;63 (10) :1761-70.|[2]Wang Y, et al. A fully human insulin-like growth factor-I receptor antibody SCH 717454 (Robatumumab) has antitumor activity as a single agent and in combination with cytotoxics in pediatric tumor xenografts. Mol Cancer Ther. 2010 Feb;9 (2) :410-8.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC741166-100 1x 100 µL
PAX6 (PAX6/1166), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
LC422398 20 µg
Archaemetzincin 2 (AMZ2) (NM_001033572) Human Over-expression Lysate
Sign In for Pricing
View Details